Jim Miller on Single Use Technology
At the BioPharma Asia Convention 2015, Jim Miller, head of the unit development office for Asia-Pacific at Sanofi gave us some insights on Single Use Technology (SUT) in Asia.
We asked him some key questions:
Single use technologies are deemed to be the future of downstreaming processing. Do you see Genentech adopting SUT in the near future?
Brown field companies tend to find difficulty in adopting SUT due to the lack of cost advantage and comparable quality and efficiency as compared to conventional stainless steel reactors. What then motivates established companies to explore into the use of single use technologies?
What are the ways to cope with quality problems due to potential extractables and leechables in SUT?
Visit the website: http://www.terrapinn.com/biopharma-asia
Read our blog: http://blogs.terrapinn.com/total-biop...
Follow us on Twitter: / totalbiopharma
Join us on LinkedIn: http://www.linkedin.com/groups?home=&...